Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Refractive Accuracy of Photoscreeners "2WIN" and "PlusoptiX" and the "Retinomax" Auto Refractor

NCT04249505 is registered in ClinicalTrials.gov with Alaska Blind Child Discovery as lead sponsor.

NCT NCT04249505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04249505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Refractive Accuracy of Photoscreeners "2WIN" and "PlusoptiX" and the "Retinomax" Auto Refractor
Lead sponsor
Alaska Blind Child Discovery
Phase
Observational
Overall status
Completed
Start date
January 9, 2020
Completion date
April 1, 2021
Enrollment
708 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

accomodation, astigmatism, hyperopia of both eyes, refractive error - myopia axial, visual impairment